
Butame Pharma Private Limited
About Butame Pharma Private Limited
Data last updated:
Butame Pharma Private Limited is a private limited company based in Gurugram, Haryana, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 January 2022.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2022PTC100881.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sandeep Kumar and Manish Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H No 944 Block C Sushant Lok 1, Gurugram, Haryana, India – 122001.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.52 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹23,390 (net margin -2.5%) and EBITDA of -₹23,390 (EBITDA margin -2.5%).
Butame Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0039030).
Company details
Recognitions & Rankings of Butame Pharma
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HR-05-0039030
Contact details
Butame Pharma Private Limited's registered office is in Gurugram, Haryana.
- Registered AddressH No 944 Block C Sushant Lok 1, Gurugram, Haryana, India – 122001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Butame Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Butame Pharma Private Limited, buy the company report.
Financials of Butame Pharma Private Limited
FY 2024 filings availableButame Pharma Private Limited reported revenue of ₹9.52 Lakh (up 1067% YoY) for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹23,390 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹23,390 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -2.5% | ||
| Net Profit Margin | -2.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Butame Pharma Private Limited, buy the company report.
Board of directors of Butame Pharma Private Limited
Butame Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar Also directs: Kaipsool Pharmatech Private Limited | Director | 28 Jan 2022 | 4 Years 9 Months | Current |
| Manish Kumar | Director | 28 Jan 2022 | 4 Years 9 Months | Current |
Peer comparison
Butame Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fvefrenz Pharmaceutical Private Limited | ₹9.6 Lakh (FY 2019) | 30.0% | Udaipur, Rajasthan, India | |||
| Amista Labs Private Limited | ₹9.56 Lakh (FY 2024) | -82.0% | Chandigarh, India | |||
| Butame Pharma Private Limitedthis company | ₹9.52 Lakh (FY 2024) | -₹23,390 | -2.5% | 1067.0% | Gurugram, Haryana, India | |
| Holid Pharmaceuticals Private Limited | ₹9.44 Lakh (FY 2025) | 29.0% | Karnal, Haryana, India |
To see the full peer comparison of Butame Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Butame Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Butame Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Butame Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Butame Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Manish Kumar was appointed as Director on 28 Jan 2022.
Frequently asked questions
Butame Pharma is an active private limited company based in Gurugram, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 January 2022 (4+ years old) and is registered under CIN U51909HR2022PTC100881.
Butame Pharma has 2 current directors:
- Sandeep Kumar - Director
- Manish Kumar - Director
The latest financial statements of Butame Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Butame Pharma is U51909HR2022PTC100881. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Butame Pharma was incorporated on 28 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Butame Pharma by revenue are Fvefrenz Pharmaceutical Private Limited, Amista Labs Private Limited, Holid Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Manish Kumar was appointed as Director on 28 Jan 2022. Sandeep Kumar was appointed as Director on 28 Jan 2022.
Yes, Butame Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Butame Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0039030).
The registered office of Butame Pharma is at H No 944 Block C Sushant Lok 1, Gurugram, Haryana, India – 122001.
Butame Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

